Adial Pharmaceuticals Inc (NASDAQ:ADIL) has a beta value of 1.20 and has seen 2.61 million shares traded in the last trading session. The company, currently valued at $4.15M, closed the last trade at $0.26 per share which meant it gained $0.01 on the day or 7.17%% during that session. The ADIL stock price is -1053.85% off its 52-week high price of $3.00 and 15.38% above the 52-week low of $0.22.

Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information

Sporting 7.17%% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ADIL stock price touched $0.26 or saw a rise of 26.68%. Year-to-date, Adial Pharmaceuticals Inc shares have moved -79.29%, while the 5-day performance has seen it change -24.88%. Over the past 30 days, the shares of Adial Pharmaceuticals Inc (NASDAQ:ADIL) have changed -63.05%.

Adial Pharmaceuticals Inc (ADIL) estimates and forecasts

The company’s shares have lost -76.73% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.05% over the past 5 years. Earnings growth for 2025 is a modest 61.03% while over the next 5 years, the company’s earnings are expected to increase by 41.31%.

ADIL Dividends

Adial Pharmaceuticals Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders

The top two institutional holders are UBS GROUP AG with over 83605.0 shares worth more than $96146.0. As of 2024-06-30, UBS GROUP AG held 1.9988% of shares outstanding.

The other major institutional holder is MANCHESTER CAPITAL MANAGEMENT LLC, with the holding of over 48097.0 shares as of 2024-06-30. The firm’s total holdings are worth over $55312.0 and represent 1.1499% of shares outstanding.